Goldcoin Health Foods Ltd has secured approval from BSE to list and trade 15,00,450 equity shares of Rs. 10 each, marking the conclusion of a capital restructuring process. The shares, bearing distinctive numbers from 1 to 15,00,450, will be admitted to dealings on the exchange effective from Friday, July 3, 2026. This development allows shareholders to trade the consolidated equity shares, which emerged from a reduction scheme sanctioned by the National Company Law Tribunal, Ahmedabad, on October 31, 2025.

The exchange notice confirms that the scrip will be categorized under the XT Group of Securities. In accordance with SEBI circulars CIR/MRD/DP/02/2012 and SEBI/HO/MRD-TPD1/CIR/P/2023/55, the security will be subject to the Trade-for-Trade segment for an initial period of 10 trading days. Additionally, the shares will be part of a special pre-open session for IPO and other categories of scrips as per regulatory directives.

Capital Restructuring Details

The listing follows a two-stage capital reduction scheme. Initially, the face value per equity share was reduced from Rs. 10 to Rs. 5. Subsequently, two equity shares of Rs. 5 each were consolidated into one equity share of Rs. 10 each. This restructuring preserved the proportionate shareholding of existing shareholders, with a conversion ratio of two old shares for one new share. The record date for this reduction was fixed as November 27, 2025.

Trading and Market Lot Information

The newly listed shares will trade under the symbol GOLDCOINHF on the BOLT System with the ISIN INE634J01027. The market lot for these securities has been set at 1 share. BSE has informed trading members that equity shares allotted in dematerialized mode have been credited under a temporary ISIN, advising due caution while dealing with these shares.

GoldCoin Health Foods Limited reported a narrowed net loss of ₹4.52 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹12.21 lakh in the previous year. Revenue from operations for FY26 stood at ₹9.07 lakh, an increase from ₹6.51 lakh in FY25. The company's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 25, 2026.

Financial Performance

For the quarter ended March 31, 2026, the company reported a net loss of ₹1.13 lakh. Total revenue for the quarter was ₹5.76 lakh, comprising ₹2.57 lakh from operations and ₹3.19 lakh from other income. Total expenses for the quarter amounted to ₹6.89 lakh. The paid-up equity share capital stood at ₹150.05 lakh as of March 31, 2026, following a consolidation of shares from a face value of ₹5 to ₹10 each effective December 11, 2025.

Capital Restructuring

During the year, the company implemented a Scheme of Reduction of Share Capital followed by a consolidation of equity shares. The National Company Law Tribunal approved the order on November 1, 2025. Consequently, the issued, subscribed, and paid-up capital was reduced by ₹1,50,04,500, and accumulated losses were reduced by the same amount. In accordance with Ind AS 33, the weighted average number of equity shares has been adjusted retrospectively for Earnings Per Share (EPS) computation.

Auditor's Report

M/s VSSB & Associates, Chartered Accountants, audited the standalone financial results. The auditor's report stated that the results give a true and fair view in conformity with Indian Accounting Standards. The report included an emphasis of matter regarding the capital reduction scheme approved by the National Company Law Tribunal. The statutory auditors issued an unmodified opinion on the financial results.

Financial Position

The company's total assets as of March 31, 2026, were ₹168.20 lakh, a decrease from ₹219.13 lakh in the previous year. Non-current assets decreased to ₹21.06 lakh from ₹78.78 lakh, primarily due to a decrease in property, plant, and equipment. Current assets increased to ₹147.14 lakh from ₹140.35 lakh. Cash and cash equivalents stood at ₹48.78 lakh as of March 31, 2026.